• Policy
• AZ, novel PNH drug 'Voydeya' may soon receive KOR approval
• by Lee, Hye-Kyung May 23, 2024 05:48am

• Policy
• 4 Pharmas make bid into low-dose statin combo drug mkt
• by Lee, Tak-Sun May 22, 2024 05:47am

• Policy
• Forxiga to maintain upper limit price until Korean mkt exit
• by Lee, Tak-Sun May 22, 2024 05:47am

• Policy
• NHIS completes pricing negotiations for Vemlidy, Brukinsa
• by Lee, Tak-Sun May 20, 2024 05:41am

• Policy
• Erwinase price increases… Imfinzi renews RSA
• by Lee, Tak-Sun May 20, 2024 05:41am

• Policy
• Daewoong develops 'Olumiant' generic…starts clinical trials
• by Lee, Hye-Kyung May 17, 2024 05:47am

• Policy
• Multiple sclerosis drug Ocrevusis approved in Korea
• by Lee, Hye-Kyung May 14, 2024 05:48am

• Policy
• BIO KOREA 2024 concludes a success
• by Lee, Hye-Kyung May 14, 2024 05:48am

• Policy
• New dementia drug Leqembi’s approval imminent in Korea
• by Lee, Hye-Kyung May 14, 2024 05:48am

• Policy
• SGLT-2 monotherapy 'Suglat' set to withdraw from KOR
• by Lee, Tak-Sun May 13, 2024 05:51am